Meprobamato

Meprobamato Brand names, Meprobamato Analogs

Meprobamato Brand Names Mixture

No information avaliable

Meprobamato Chemical_Formula

C₂₀H₂₃NS

Meprobamato RX_link

No information avaliable

Meprobamato fda sheet

Meprobamato msds (material safety sheet)

Meprobamato Synthesis Reference

No information avaliable

Meprobamato Molecular Weight

309.469 g/mol

Meprobamato Melting Point

< 25 ^oC

Meprobamato H₂O Solubility

Soluble as HCl salt

Meprobamato State

Liquid

Meprobamato LogP

5.7

Meprobamato Dosage Forms

Tablets (oral, 1 mg)

Meprobamato Indication

Used for the symptomatic treatment of parkinsonism.

Meprobamato Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Meprobamato Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Meprobamato side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Meprobamato Patient Information

Meprobamato Organisms Affected

Humans and other mammals